Vault-13

Bruce & Co., Inc.

CHICAGO, IL · CIK 1358331 · 13F filing filed 2022-05-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$489.1m reported value -2.2% vs Q4 2021
32positions
70.6%in top 10
2 new 1 added 9 reduced 1 sold out vs Q4 2021

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMERCO COM UHAL UHAL 75,355 $45.0m9.20% 9.20% UnchangedShares held: Q2 2021 93.4k, Q3 2021 79.8k, Q4 2021 75.4k, Q1 2022 75.4k
2 FPL GROUP INC COM COM 490,000 $41.5m8.49% 8.49% ReducedShares held: Q2 2021 543.0k, Q3 2021 501.4k, Q4 2021 490.4k, Q1 2022 490.0k -400 -400 -0.1%
3 ABBVIE INC COM ABBV ABBV 243,500 $39.5m8.07% 8.07% ReducedShares held: Q2 2021 368.1k, Q3 2021 303.5k, Q4 2021 303.5k, Q1 2022 243.5k -60.0k -60,000 -19.8%
4 ALLSTATE CORP COM ALL ALL 279,300 $38.7m7.91% 7.91% ReducedShares held: Q2 2021 323.8k, Q3 2021 299.8k, Q4 2021 299.3k, Q1 2022 279.3k -20.0k -20,000 -6.7%
5 CMS ENERGY CORP COM CMS CMS 468,500 $32.8m6.70% 6.70% UnchangedShares held: Q2 2021 491.8k, Q3 2021 468.5k, Q4 2021 468.5k, Q1 2022 468.5k
6 DUKE ENERGY CORP NEW COM NEW DUK DUK 286,200 $32.0m6.53% 6.53% UnchangedShares held: Q2 2021 297.5k, Q3 2021 286.2k, Q4 2021 286.2k, Q1 2022 286.2k
7 VALEANT PHARMACEUTICALS INTL COM COM 1,381,000 $31.6m6.45% 6.45% UnchangedShares held: Q2 2021 1.4m, Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m
8 XCEL ENERGY INC COM XEL XEL 412,500 $29.8m6.09% 6.09% UnchangedShares held: Q2 2021 435.1k, Q3 2021 412.5k, Q4 2021 412.5k, Q1 2022 412.5k
9 PFIZER INC COM PFE PFE 542,700 $28.1m5.74% 5.74% ReducedShares held: Q2 2021 566.6k, Q3 2021 544.7k, Q4 2021 543.7k, Q1 2022 542.7k -1.0k -1,000 -0.2%
10 Merck & Co Inc COM COM 323,700 $26.6m5.43% 5.43% UnchangedShares held: Q2 2021 330.2k, Q3 2021 323.7k, Q4 2021 323.7k, Q1 2022 323.7k
11 APPLE INC COM AAPL AAPL 137,400 $24.0m4.91% 4.91% ReducedShares held: Q2 2021 280.2k, Q3 2021 242.7k, Q4 2021 167.4k, Q1 2022 137.4k -30.0k -30,000 -17.9%
12 AT&T INC COM T T 922,000 $21.8m4.45% 4.45% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 922.0k
13 ABBOTT LABS COM ABT ABT 167,600 $19.8m4.06% 4.06% ReducedShares held: Q2 2021 254.6k, Q3 2021 177.6k, Q4 2021 177.6k, Q1 2022 167.6k -10.0k -10,000 -5.6%
14 Paratek CV 4.75% · principal CV 4.75% · principal 16,600,000 $14.6m2.99% 2.99% UnchangedPrincipal held: Q2 2021 16.8m, Q3 2021 16.6m, Q4 2021 16.6m, Q1 2022 16.6m
15 GENERAL ELECTRIC CO COM COM 104,375 $9.6m1.95% 1.95% UnchangedShares held: Q2 2021 106.2k, Q3 2021 104.4k, Q4 2021 104.4k, Q1 2022 104.4k
16 AVISTA CORP COM AVA AVA 205,000 $9.3m1.89% 1.89% UnchangedShares held: Q2 2021 208.5k, Q3 2021 205.0k, Q4 2021 205.0k, Q1 2022 205.0k
17 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 222,105 $7.2m1.47% 1.47% ReducedShares held: Q2 2021 402.1k, Q3 2021 402.1k, Q4 2021 402.1k, Q1 2022 222.1k -180.0k -180,000 -44.8%
18 NEWMONT CORP COM NEM NEM 65,000 $5.2m1.06% 1.06% UnchangedShares held: Q2 2021 65.0k, Q3 2021 65.0k, Q4 2021 65.0k, Q1 2022 65.0k
19 SIRIUS XM HOLDINGS INC COM SIRI SIRI 757,843 $5.0m1.03% 1.03% ReducedShares held: Q2 2021 1.2m, Q3 2021 857.8k, Q4 2021 857.8k, Q1 2022 757.8k -100.0k -100,000 -11.7%
20 PARATEK PHARMACEUTICALS INC COM PRTK PRTK 1,557,312 $4.6m0.95% 0.95% AddedShares held: Q2 2021 1.2m, Q3 2021 1.3m, Q4 2021 1.4m, Q1 2022 1.6m +114.0k +114,000 7.9%
21 EDAP TMS S A SPONSORED ADR FOCL FOCL 565,652 $4.1m0.84% 0.84% UnchangedShares held: Q2 2021 611.4k, Q3 2021 565.7k, Q4 2021 565.7k, Q1 2022 565.7k
22 Acorda Theraputics CV 6.0% · principal CV 6.0% · principal 5,000,000 $3.8m0.77% 0.77% UnchangedPrincipal held: Q2 2021 4.0m, Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 5.0m
23 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 315,182 $2.6m0.53% 0.53% UnchangedShares held: Q2 2021 0, Q3 2021 407.4k, Q4 2021 315.2k, Q1 2022 315.2k
24 ASHLAND INC NEW COM COM 25,000 $2.5m0.50% 0.50% UnchangedShares held: Q2 2021 25.0k, Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k
25 FATE THERAPEUTICS INC COM FATE FATE 57,000 $2.2m0.45% 0.45% UnchangedShares held: Q2 2021 62.0k, Q3 2021 57.0k, Q4 2021 57.0k, Q1 2022 57.0k
26 ACCELERATE DIAGNOSTICS INC NOTE 2.500% 3/1 · principal AXDX 2.5 03.15.23 · principal AXDX 2.5 03.15.23 3,000,000 $2.0m0.40% 0.40% NewPrincipal held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 3.0m
27 IGM BIOSCIENCES INC COM IGMS IGMS 55,000 $1.5m0.30% 0.30% UnchangedShares held: Q2 2021 55.0k, Q3 2021 55.0k, Q4 2021 55.0k, Q1 2022 55.0k
28 MANNKIND CORP COM NEW MNKD MNKD 395,073 $1.5m0.30% 0.30% UnchangedShares held: Q2 2021 395.1k, Q3 2021 395.1k, Q4 2021 395.1k, Q1 2022 395.1k
29 ORGANON & CO COMMON STOCK OGN OGN 31,970 $1.1m0.23% 0.23% ReducedShares held: Q2 2021 0, Q3 2021 32.4k, Q4 2021 32.4k, Q1 2022 32.0k -400 -400 -1.2%
30 VIATRIS INC COM VTRS VTRS 61,512 $669.0k0.14% 0.14% UnchangedShares held: Q2 2021 0, Q3 2021 61.5k, Q4 2021 61.5k, Q1 2022 61.5k
31 NOVAVAX INC NOTE 3.750% 2/0 · principal NVAX 3.75 02.01.23 · principal NVAX 3.75 02.01.23 600,000 $642.0k0.13% 0.13% UnchangedPrincipal held: Q2 2021 600.0k, Q3 2021 600.0k, Q4 2021 600.0k, Q1 2022 600.0k
32 RLI CORP COM RLI RLI 2,400 $269.0k0.06% 0.06% UnchangedShares held: Q2 2021 22.8k, Q3 2021 2.4k, Q4 2021 2.4k, Q1 2022 2.4k

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
FLOTEK INDS INC DEL 421,671 $476.0k421.7k shares